𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Malignant transformation of human bronchial epithelial cells with the tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone

✍ Scribed by Hongning Zhou; Gloria M. Calaf; Tom K. Hei


Publisher
John Wiley and Sons
Year
2003
Tongue
French
Weight
263 KB
Volume
106
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


Sufficient evidence has demonstrated that cigarette smoking is causally associated with various types of human cancers. In the United States, about 90% of deaths from lung cancer among men and 79% of those among women are associated with smoking. Tobacco-specific nitrosamines are formed from nicotine and related tobacco alkaloids and are the most carcinogenic compounds of tobacco smoke. The most potent N-nitrosamine contained in tobacco smoke is 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, NNK. In the our study, the oncogenic transforming effects of graded doses of NNK were examined using papillomavirus-immortalized human bronchial epithelial cells. Growth kinetics, saturation density, resistance to serum-induced terminal differentiation, anchorage independent growth and tumorigenicity in nude mice were used to investigate the various stages of transformation in bronchial epithelial cells. We show here that immortalized human bronchial epithelial cells in culture can be malignantly transformed by treatment with NNK (100 microg/ml or 400 microg/ml) for 7 days. Transformed cells produced progressively growing subcutaneous tumors upon inoculation into nude mice. Immunofluorescence staining for keratin expression confirmed the epithelial nature of the tumor cells. Increased expression of p16, beta-catenin and PCNA in the established cell lines were detected by immunofluorescence staining and quantified by confocal microscopy. These data suggested that NNK can induce malignant transformation of human bronchial epithelial cells, and the tumor cell lines established are useful models in investigating the carcinogenic mechanism(s) of NNK.


📜 SIMILAR VOLUMES


Genetic variability in the metabolism of
✍ Monica Ter-Minassian; Kofi Asomaning; Yang Zhao; Feng Chen; Li Su; Steven G. Car 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 French ⚖ 354 KB

## Abstract Urinary metabolites of the tobacco‐specific nitrosamine 4‐(methylnitrosamino)‐1‐(3‐pyridyl)‐1‐butanone (NNK), 4‐(methylnitrosamino)‐1‐(3‐pyridyl)‐1‐butanol (NNAL) and its glucuronides, termed total NNAL, have recently been shown to be good predictors of lung cancer risk, years before di

Racial differences in exposure and glucu
✍ Joshua E. Muscat; Mirjana V. Djordjevic; Stephen Colosimo; Steven D. Stellman; J 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB

## Abstract ## BACKGROUND In the United States, Blacks who smoke cigarettes have a higher mean blood concentration of the nicotine metabolite cotinine than White smokers. It has not been determined whether there are racial differences in the exposure to the cigarette smoke carcinogen 4‐(methylnitr

Mutational specificities of environmenta
✍ Jianli Jiao; Barry W. Glickman; Maria Zielenska; Joseph B. Guttenplan; Liu-Yu Xi 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 430 KB

## Abstract To investigate the influence of different types of metabolic activation (9,000 x __g__ supernatant (S9) activation vs. a host‐mediated approach) on 4‐(methylnitrosamino)‐1‐(3‐pyridyl)‐1‐butanone (NNK)‐induced mutational specificity, we determined by DNA sequencing the distribution of fo